Frances Perkins, who left her progressive mark on New York City, New York state, the nation and Cornell, will be celebrated in an exhibit opening June 7 in the ILR School, where she served on the faculty until she died at age 85 in 1965.
A new study from Weill Cornell Medicine researchers helps explain why having ApoE4 – the gene variant most closely linked to Alzheimer’s disease – increases the risk of neurodegeneration and white matter damage.
Dr. Jennifer Downs of Weill Cornell Medicine is collaborating with Tanzanian researchers to treat schistosomiasis, a parasitic worm infection affecting 250 million people worldwide.
About half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to a report from Weill Cornell Medicine and Dana-Farber Cancer Center investigators.
Researchers have used a cutting-edge model system to uncover the mechanism by which SARS-CoV-2 induces new cases of diabetes and worsens complications in people who already have it.
Weill Cornell Medicine has received $4.2 million to study how the immune system in some people infected with HIV can keep the virus under control, which could lead to new therapies.
A new consortium co-led by Weill Cornell Medicine has been awarded a five-year, $31 million grant from the NIH’s National Institute of Allergy and Infectious Diseases to accelerate the development of better treatment regimens for tuberculosis.
Chakrabarti joined Cornell AAP this semester as the Thomas J. Baird Visiting Critic to share his vast knowledge and practical experience improving cities and communities with NYC-based Advanced Urban Design students.
